Three health funds have filed a lawsuit against AstraZeneca alleging the pharmaceutical company has promoted its antipsychotic drug, Seroquel, for off-label uses, and that doctors have been prescribing it instead of less expensive and more effective drugs for some conditions.
A judge has shot down Taiwanese chip maker MediaTek Inc.’s request to file a summary judgment motion as part of its defense against a patent suit brought by Japanese electronics maker Matsushita Electric Industrial Co. over integrated circuit chips.
A House subcommittee has approved a bill aimed at making drastic changes in patent law, setting up congressional debate over whether the changes will improve or impede innovation in the U.S.
After a year and a half of negotiations with shareholders, SeraCare Life Sciences Inc. has come out of Chapter 11 and settled a class action suit for $3 million over allegations of securities fraud.
Boston Scientific Corp. is in negotiations to settle approximately 1,350 product liability suits it took on when it beat out Johnson & Johnson last year for the right to acquire Guidant Corp. for around $27 billion, published reports say.
The multidistrict litigation against the makers of controversial hormone replacement drugs has ballooned to over 3,900 consolidated complaints, with a judicial panel this week adding more cases to the list.
The office of the U.S. Trade Representative’s annual report identifying the most serious offenders of intellectual property laws can theoretically lead to a loss of trade benefits for blacklisted countries, but legal experts say tangible improvements to IP enforcement and protection will take much more than the threat of sanctions.
Not content to bring just one suit against Teva Pharmaceuticals USA over a generic version of asthma and allergy medication Singulair, Merck & Co. Inc. let a Barbados-based subsidiary file a second patent suit against the Israeli generics maker on Monday.
A patent issued Tuesday and assigned to a Johnson & Johnson subsidiary has spawned two lawsuits over the lucrative and highly litigious market for drug-eluting stents.
A Michigan-based biotechnology company has fought back against a rival company’s lawsuit claiming infringement of three patents covering medical diagnostic kits.
BioSafe Medical Technologies Inc. has ducked out of bankruptcy after a judge on Tuesday granted a joint motion to dismiss an involuntary Chapter 11 petition filed on behalf of the home medical testing company’s creditors.
A judge dismissed a lawsuit Tuesday in which Bavarian Nordic had accused rival pharmaceutical company Acambis PLC of producing a smallpox vaccine with stolen research.
Sanofi-Aventis has filed a patent suit over Ambien CR, marking at least the second time since February the French pharmaceutical giant has attempted to keep a generic competitor out of the multibillion-dollar market for the insomnia drug.
Abbott Laboratories has filed a lawsuit against an Indian pharmaceutical company and its U.S. subsidiary in a move to stave off efforts to horn in on the billion-dollar U.S. market for the drug Depakote.
A married couple has slapped AstraZeneca with a lawsuit, accusing the pharmaceutical giant of illegally producing and promoting a treatment for the early stages of breast cancer that allegedly causes severe injuries, including bone deterioration.
Kinetic Concepts Inc. and a division of Wake Forest University went on the warpath Tuesday, filing patent infringement suits against their rivals over vacuum-assisted wound closure technology.
Legislation has been introduced into the U.S. House of Representatives that would bar the U.S. Food and Drug Administration from collecting drug user fees that manufacturers pay to seek the agency’s approval for their products.
Claiming that two recent Supreme Court decisions have undercut a jury ruling which resulted in the largest damages award ever in a patent case, Microsoft Corp. filed a motion on Monday seeking a new trial in its case with rival Alcatel-Lucent.
Claims by a group of sacked Hoffman-La Roche employees that the drug maker outsourced their jobs to avoid future pension payments have been dismissed by an appeals court on a technicality.
The U.S. Supreme Court has declined to tackle the issue of how much authority appeals courts have to scuttle claims construction rulings made by lower courts.